Pollutants and puberty: new study tracks 650 kids in guadeloupe
NCT ID NCT06653660
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study follows 650 children in Guadeloupe who were exposed to organochlorine pollutants like chlordecone before birth. Researchers will track their cognitive development and puberty timing through tests and blood samples. The goal is to understand if these chemicals affect growth and thinking skills.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If this study finds links between pollutants and development, it could guide future policies to protect children's health.
- What could go wrong
- This is an observational study, not a treatment trial. It can show associations but not prove cause and effect. Results may take years and might not lead to direct changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 650 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2022
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Be born to a mother whose pregnancy was included in the Timoun cohort (2004 - 2007)
- Ages
-
16 to 22 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Be born to a mother whose pregnancy was included in the Timoun cohort (2004 - 2007) and whose parents agreed to be contacted later. * Residing in Guadeloupe at the peripubertal age * Affiliation to a social security scheme * Agreement to participate in the study and informed consent signed by the minor * Study participation agreement and informed consent signed by the parents Exclusion Criteria: * Refusal to participate in the research
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postnatal exposure are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU of Guadeloupe
RECRUITINGPointe-à-Pitre, Guadeloupe, 97159, Guadeloupe